Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: A prospective randomized controlled.

Slides:

Advertisements

Similar presentations

The “occasional open heart surgeon” revisited

Advertisements

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery Emmanuel Akintoye, MD, MPH, Frank Sellke, MD,

Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis

Off-pump coronary artery bypass grafting does not preserve renal function better than on-pump coronary artery bypass grafting: Results of a case-matched.

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database Andrew W. ElBardissi,

The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades Jeanne Shen, BS, Shelly Lall,

Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery? Niv Ad, MD, Sari D. Holmes, PhD, Deborah J.

Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial Niv Ad, MD, Sari D. Holmes,

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary.

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Thromboresistant surfaces with low-dose anticoagulation alleviate clopidogrel-related complications in patients undergoing coronary artery bypass grafting

CD133+ cells: How could they have an IMPACT?

Improving health care by embracing Systems Theory

Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass.

Neel R. Sodha, MD, Frank W. Sellke, MD

Right internal thoracic artery or saphenous vein grafting

Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? Khalil Masabni, MD,

Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft.

Off-pump versus on-pump coronary artery bypass grafting: A systematic review and meta-analysis of propensity score analyses Oliver Kuss, PhD, Benita.

Multilevel data analysis: What? Why? How?

The use of vancomycin paste to reduce sternal wound infections after cardiac surgery— why is this still a “sticky” subject Harold L. Lazar, MD The Journal.

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Resuscitation practices in cardiac surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality.

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial.

For everything there is a season

Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J

Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery? Niv Ad, MD, Linda.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

A. Thomas Pezzella, MD, Sari D

Shengshou Hu, MD, Xin Yuan, MD, PhD

The thoracoabdominal saga and heroes

Treatment of deep sternal wound infections after coronary artery bypass grafting by means of injection of platelet gel: An evolving technology Erez Kachel,

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting Castigliano M. Bhamidipati,

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study Uzi Izhar,

The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery Niv Ad, MD, Sari D. Holmes, PhD, Jay.

Apples remain apples NO matter what

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

How do we follow up our patients

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa.

Presentation transcript:

Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: A prospective randomized controlled trial Shalin P. Desai, MD, Linda L. Henry, PhD, Sari D. Holmes, PhD, Sharon L. Hunt, MBA, Chidima T. Martin, BS, CCRP, Shrinivas Hebsur, MD, Niv Ad, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 2, Pages 318-325 (February 2012) DOI: 10.1016/j.jtcvs.2011.10.070 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Trial design. CVICU, Cardiovascular intensive care unit; OR, odds ratio; CABG, coronary artery bypass grafting; PHQ9, Patient Health Questionnaire 9; CBC, complete blood count; BMP, basic metabolic panel; HgBA1C, hemoglobin A1C; LFT, liver function test; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Gtt, glucose tolerance test; Glu, glucose; MACE, major adverse cardiac event. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 318-325DOI: (10.1016/j.jtcvs.2011.10.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Flow of participants. CABG, Coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 318-325DOI: (10.1016/j.jtcvs.2011.10.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Treatment difference and 95% confidence interval for noninferiority of perioperative complications and outcomes: intention-to-treat analyses (A), completer analyses (B), and per protocol analyses (C). DSW, Deep sternal wound infection; MACE, major adverse cardiac events; LOS, length of stay. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 318-325DOI: (10.1016/j.jtcvs.2011.10.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions